Role of paclitaxel, ifosfamide, and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck

被引：0
|
作者：
Shin, DM
Glisson, BS
Khuri, FR
Hong, WK
Lippman, SM
机构：
[1] Univ Texas, MD Anderson Cancer Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Cancer Ctr, Dept Clin Canc Prevent, Houston, TX 77030 USA
来源：
SEMINARS IN ONCOLOGY | 1998年 / 25卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：40 / 44
页数：5
相关论文
共 50 条
  • [31] Immunotherapy in recurrent and or metastatic squamous cell carcinoma of the head and neck
    Saada-Bouzid, Esma
    Peyrade, Frederic
    Guigay, Joel
    [J]. CURRENT OPINION IN ONCOLOGY, 2019, 31 (03) : 146 - 151
  • [32] Chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck
    Fanucchi, M
    Khuri, FR
    [J]. SEMINARS IN ONCOLOGY, 2004, 31 (06) : 809 - 815
  • [33] A phase II study of ifosfamide in recurrent squamous cell carcinoma of the head and neck
    Huber, MH
    Lippman, SM
    Benner, SE
    Shirinian, M
    Dimery, IW
    Dunnington, JS
    Hong, WK
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1996, 19 (04): : 379 - 383
  • [34] Paclitaxel and carboplatin in patients with metastatic or recurrent squamous cell carcinoma of the head and neck. A phase II study.
    Hiller, S
    Mergenthaler, HG
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 507S - 507S
  • [35] CARBOPLATIN, PACLITAXEL AND PEMBROLIZUMAB FOR THE FIRST LINE TREATMENT OF RECURRENT AND/OR METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA
    Valadez, Angelica
    Welsh, Madeleine
    Kim, Christine
    Johns, Angela
    Algazi, Alain
    Kang, Hyunseok
    Kang, Hyunseok
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A118 - A118
  • [36] A phase II study of combination chemotherapy with capecitabine and cisplatin in patients with metastatic or recurrent squamous cell carcinoma of the head and neck
    Won, Y. -W.
    Park, Y. H.
    Ahn, M. J.
    Do, I. -G.
    Ko, Y. H.
    Park, K.
    [J]. ANNALS OF ONCOLOGY, 2011, 22 (02) : 417 - 423
  • [37] Capecitabine (C) in combination with cisplatin (P) for recurrent and/or metastatic squamous cell carcinoma of head and neck (HN)
    Lopez-Argumedo, Gonzalo
    Perez-Hoyos, Teresa
    Rubio, Itziar
    Munoz, Alberto
    Mane, Joan M.
    Viteri, Ainhoa
    Pardo, Marta
    Barcelo, Ramon
    Martinez, Alejandro
    Lopez-Vivanco, Guillermo
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 140 - 140
  • [38] Phase II study with docetaxel and cisplatin in the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck
    Gedlicka, C
    Formanek, M
    Selzer, E
    Burian, M
    Kornfehl, J
    Fiebiger, W
    Cartellieri, M
    Marks, B
    Kornek, GV
    [J]. ONCOLOGY, 2002, 63 (02) : 145 - 150
  • [39] Phase II trial of irinotecan plus cisplatin in patients with recurrent or metastatic squamous carcinoma of the head and neck
    Gilbert, Jill
    Cmelak, Anthony
    Shyr, Yu
    Netterville, James
    Burkey, Brian B.
    Sinard, Robert J.
    Yarbrough, Wendall G.
    Chung, Christine H.
    Aulino, Joseph M.
    Murphy, Barbara A.
    [J]. CANCER, 2008, 113 (01) : 186 - 192
  • [40] Paclitaxel, ifosfamide, and carboplatin (TIC) in patients with recurrent or metastatic head and neck cancer: Preliminary results
    Shin, DM
    Khuri, FR
    Ginsberg, L
    Papadimitrakopoulou, V
    Glisson, BS
    Hong, WK
    [J]. SEMINARS IN ONCOLOGY, 1999, 26 (01) : 135 - 135
12345